Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Intruder Alert

Dr Helen Whitby at Phenomenex explores new research revealing liquid chromatography-tandem mass spectrometry may be the solution to prevent contaminates, such as host cell proteins, stopping a drug from progressing to clinical trials.

Dr Helen Whitby at Phenomenex (October 2017)

Keywords: Host cell proteins, Identifying contaminates, Monoclonal antibodies, Purification

    View full article    |    Back to Biopharma section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |